BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7757988)

  • 1. Efficient gene transfer with adeno-associated virus-based plasmids complexed to cationic liposomes for gene therapy of human prostate cancer.
    Vieweg J; Boczkowski D; Roberson KM; Edwards DW; Philip M; Philip R; Rudoll T; Smith C; Robertson C; Gilboa E
    Cancer Res; 1995 Jun; 55(11):2366-72. PubMed ID: 7757988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene modification of primary tumor cells for active immunotherapy of human breast and ovarian cancer.
    Philip R; Clary B; Brunette E; Kilinski L; Murugesh D; Sorich M; Yau J; Lebkowski J; Lyerly HK; Philip M
    Clin Cancer Res; 1996 Jan; 2(1):59-68. PubMed ID: 9816091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy of prostate cancer in the Dunning rat model: use of cytokine gene modified tumor vaccines.
    Vieweg J; Rosenthal FM; Bannerji R; Heston WD; Fair WR; Gansbacher B; Gilboa E
    Cancer Res; 1994 Apr; 54(7):1760-5. PubMed ID: 8137291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of combined interleukin 2 and B7.1 vaccination strategy is dependent on the sequence and order: a liposome-mediated gene therapy treatment for bladder cancer.
    Larchian WA; Horiguchi Y; Nair SK; Fair WR; Heston WD; Gilboa E
    Clin Cancer Res; 2000 Jul; 6(7):2913-20. PubMed ID: 10914741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adeno-associated viral-mediated gene transfer to hepatoma: thymidine kinase/interleukin 2 is more effective in tumor killing in non-ganciclovir (GCV)-treated than in GCV-treated animals.
    Su H; Lu R; Ding R; Kan YW
    Mol Ther; 2000 Jun; 1(6):509-15. PubMed ID: 10933975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmid DNA gene therapy: studies with the human interleukin-2 gene in tumor cells in vitro and in the murine B16 melanoma model in vivo.
    Parker SE; Khatibi S; Margalith M; Anderson D; Yankauckas M; Gromkowski SH; Latimer T; Lew D; Marquet M; Manthorpe M; Hobart P; Hersh E; Stopeck AT; Norman J
    Cancer Gene Ther; 1996; 3(3):175-85. PubMed ID: 8725882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside.
    O'Malley BW; Li D; McQuone SJ; Ralston R
    Laryngoscope; 2005 Mar; 115(3):391-404. PubMed ID: 15744147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination gene therapy using multiple immunomodulatory genes transferred by a defective infectious single-cycle herpes virus in squamous cell cancer.
    Kim SH; Carew JF; Kooby DA; Shields J; Entwisle C; Patel S; Shah JP; Fong Y
    Cancer Gene Ther; 2000 Sep; 7(9):1279-85. PubMed ID: 11023201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo cytokine gene therapy of human tumor xenografts in SCID mice by liposome-mediated DNA delivery.
    Egilmez NK; Cuenca R; Yokota SJ; Sorgi F; Bankert RB
    Gene Ther; 1996 Jul; 3(7):607-14. PubMed ID: 8818648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient inducation of local and systemic antitumor immune response by liposome-mediated intratumoral co-transfer of interleukin-2 gene and interleukin-6 gene.
    Cao X; Wang Q; Ju DW; Tao Q; Wang J
    J Exp Clin Cancer Res; 1999 Jun; 18(2):191-200. PubMed ID: 10464706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfection of primary tumor cells and tumor cell lines with plasmid DNA/lipid complexes.
    Stopeck AT; Hersh EM; Brailey JL; Clark PR; Norman J; Parker SE
    Cancer Gene Ther; 1998; 5(2):119-26. PubMed ID: 9570303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination with IL-12 gene-modified autologous melanoma cells: preclinical results and a first clinical phase I study.
    Sun Y; Jurgovsky K; Möller P; Alijagic S; Dorbic T; Georgieva J; Wittig B; Schadendorf D
    Gene Ther; 1998 Apr; 5(4):481-90. PubMed ID: 9614572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicomponent gene therapy vaccines for lung cancer: effective eradication of established murine tumors in vivo with interleukin-7/herpes simplex thymidine kinase-transduced autologous tumor and ex vivo activated dendritic cells.
    Sharma S; Miller PW; Stolina M; Zhu L; Huang M; Paul RW; Dubinett SM
    Gene Ther; 1997 Dec; 4(12):1361-70. PubMed ID: 9472560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NK cell-mediated anti-tumor immune response to human prostate cancer cell, PC-3: immunogene therapy using a highly secretable form of interleukin-15 gene transfer.
    Suzuki K; Nakazato H; Matsui H; Hasumi M; Shibata Y; Ito K; Fukabori Y; Kurokawa K; Yamanaka H
    J Leukoc Biol; 2001 Apr; 69(4):531-7. PubMed ID: 11310838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-2 gene-transduced human leukemic cells induce major histocompatibility complex-restricted and -unrestricted anti-leukemic effectors in mixed lymphocyte-tumor cultures.
    Cignetti A; Guarini A; Gillio Tos A; Reato G; Foa R
    Cancer Gene Ther; 2000 Feb; 7(2):167-76. PubMed ID: 10770624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo transfection of plasmid DNA in the Dunning prostate tumor R3327-AT1 is enhanced by focused ultrasound.
    Huber PE; Pfisterer P
    Gene Ther; 2000 Sep; 7(17):1516-25. PubMed ID: 11001372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate-specific expression of the diphtheria toxin A chain (DT-A): studies of inducibility and specificity of expression of prostate-specific antigen promoter-driven DT-A adenoviral-mediated gene transfer.
    Li Y; McCadden J; Ferrer F; Kruszewski M; Carducci M; Simons J; Rodriguez R
    Cancer Res; 2002 May; 62(9):2576-82. PubMed ID: 11980652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonviral genetic transfer of Fas ligand induced significant growth suppression and apoptotic tumor cell death in prostate cancer in vivo.
    Nakanishi H; Mazda O; Satoh E; Asada H; Morioka H; Kishida T; Nakao M; Mizutani Y; Kawauchi A; Kita M; Imanishi J; Miki T
    Gene Ther; 2003 Mar; 10(5):434-42. PubMed ID: 12601398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenovirus-mediated interferon-beta gene transfer inhibits angiogenesis in and progression of orthotopic tumors of human prostate cancer cells in nude mice.
    Lee J; Wang A; Hu Q; Lu S; Dong Z
    Int J Oncol; 2006 Dec; 29(6):1405-12. PubMed ID: 17088978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intratumoral pharmacokinetics and in vivo gene expression of naked plasmid DNA and its cationic liposome complexes after direct gene transfer.
    Nomura T; Nakajima S; Kawabata K; Yamashita F; Takakura Y; Hashida M
    Cancer Res; 1997 Jul; 57(13):2681-6. PubMed ID: 9205077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.